Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Gemcitabine|DRUG: docetaxel
Sponsor: Eli Lilly and Company